LICC: L-BLP25 in Patients with Colorectal Cancer after resection of liver metastases - a randomized, placebo-controlled, multicenter, multinational, double blinded phase II trial
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Primary objectives: Comparative evaluation of recurrence-free survival time and three year overall survial between the treatment groups L-BLP25 plus cyclophosphamide versus placebo vaccination and saline infusion Primary endpoints: Recurrence-Free Survival (RFS) time and three year overall survival based on standard imaging.
创建时间：
2011-09-15
